NetworkNewsBreaks – CytoDyn Inc. (CYDY) President and CEO Featured in Uptick Newswire’s Stock Day Podcast

Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced the featured interview of its President and CEO Nader Z. Pourhassan, Ph.D. with Stock Day’s Everett Jolly. Jolly initiated the discussion by asking about CytoDyn’s PRO 140. The company’s flagship product is a humanized IgG4 monoclonal antibody that is designed to bind to cellular receptor CCR5, which plays various roles with implications in HIV, tumor metastasis and immune signaling. Pending FDA approval, which the company hopes to secure in Q4 2019, Pourhassan indicates that PRO 140 may be available to the public in 2020.  “Most biotech companies, when they finish the biologic application, they have an 85% chance to get approved. 9 out of 10 who don’t get approved is because of the safety of the product. Our product has received fast track designation due to having great safety among all of the approved drugs,” Nader Z. Pourhassan, Ph.D., president and CEO of CytoDyn, stated in the news release.

To hear the Stock Day Podcast featuring the interview, visit http://nnw.fm/kYJU8

To view the full press release, visit http://nnw.fm/4Q7xo

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Launches Comprehensive POS Solution, Aptito NetworkNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) QuadSight Wins 2019 CES Innovation Award NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) Brings to Market its Cranberry & Shortbread Gummies: 2018 Holiday Limited Edition

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Daily Sports Club

Juventus beats Valencia 1-0 to progress to round of 16

Dec 10, 2018

TURIN, Italy — Cristiano Ronaldo set up Mario Mandzukic for the winning goal as Juventus secured a spot in Champions League knockout stage with a 1-0 win over Valencia on Tuesday. Ronaldo got away from his marker with some quick footwork before rolling the ball across for Mario Mandzukic to tap into the net in the 59th minute. The 33-year-old Ronaldo has been involved in 44 percent of Juve's goals this season, having scored 10 and assisted six others. And Mandzukic is clearly reaping the benefits. The Croatia international scored five goals in 32 league matches last season and already...

Ireland change 14 for test against US Eagles

Dec 10, 2018

DUBLIN — Only center Garry Ringrose has kept his run-on jersey in the Ireland side meeting the United States in a rugby international on Saturday at Lansdowne Road. Ringrose was the only repeat starter from the 16-9 win over New Zealand last weekend, while prop Cian Healy and flanker Josh van Der Flier were in the reserves. Lock Iain Henderson, flanker Jordi Murphy, and flyhalf Joey Carbery were replacements against the All Blacks and promoted to starters on Thursday, while reserve scrumhalf Luke McGrath was retained. Flanker Rhys Ruddock captains the second-string side which more closely resembles the one which...

Ireland topple All Blacks 16-9 at home for first time

Dec 10, 2018

DUBLIN — Ireland beat the All Blacks 16-9 at home for the first time on Saturday and laid a major marker for the Rugby World Cup next year. The blockbuster matchup of No. 1 and No. 2, the champions of each hemisphere, lived up to the hype. Ireland edged a rugged first half, and in a more open second half produced a classic try and kept New Zealand tryless for the first time since last year's Lions tour. At a highly charged Lansdowne Road, Ireland became the only team to beat New Zealand twice since the All Blacks won a...

Ronaldo ends San Siro hoodoo as Juventus beats Milan 2-0

Dec 10, 2018

MILAN — Cristiano Ronaldo ended his San Siro hoodoo to help Juventus to a 2-0 win after AC Milan forward Gonzalo Higuain missed a penalty against his former team on Sunday. Higuain left Juventus in the offseason following the signing of Ronaldo and he had a nightmare game as he was also sent off seven minutes from time for dissent after being booked for a foul on Medhi Benatia. Mario Mandzukic scored early on and Ronaldo sealed the result nine minutes from the end as Serie A leader Juventus won at Milan to restore its six-point advantage over second-placed Napoli,...

Napoli fights back to beat Genoa 2-1 and stay close to Juve

Dec 10, 2018

MILAN — In a match which had to be suspended for nearly 15 minutes because of rain, Napoli almost saw its Serie A title hopes given a dousing, too. Napoli fought back from a goal down and needed a late own goal to win at Genoa 2-1 on Saturday and keep within sight of leader Juventus. Carlo Ancelotti's side cut the gap to three points to Juventus, which visits AC Milan on Sunday. Inter Milan can move back level on points with a win at Atalanta, also on Sunday. "Proud of my players who pushed through less than desirable conditions...

Search

About Us

From transfer news, tactical analysis to predictions, get only the best of the world of sports daily with Daily Sports Club.

Contact us: sales[at]dailysportsclub.com

Subscribe Now!